Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson's disease and related disorders, today...

UAE welcomes Crypto.com's decision to set up regional base in Dubai and its support for inaugural Investopia conference Crypto.com aims to play a role in furthering global financial innovation...

DALLAS, March 28, 2022 PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing optogenetic gene therapies to treat retinal degenerative diseases, today...

GDT002 shown to have a potent anti-tumor activity across a broad spectrum of solid and liquid tumors Ovarian cancer selected from broad screening of solid tumor types as the indication for GDT002...

The 8th China EV 100 was held in Beijing from March 25th to 27th, with the theme of "Embracing a New Stage of NEV's Market-Driven Growth". In-depth discussions were made on policy adjustment in...